share_log

HC Wainwright & Co. Maintains Buy on Relay Therapeutics, Lowers Price Target to $16

HC Wainwright & Co. Maintains Buy on Relay Therapeutics, Lowers Price Target to $16

HC Wainwright & Co. 维持对relay therapeutics的买入评级,下调目标价至16美元。
Benzinga ·  12/04 20:01  · 评级/大行评级

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price target from $20 to $16.

HC Wainwright & Co. 分析师Robert Burns认为relay therapeutics (纳斯达克:RLAY) 买入评级,将目标股价从$20调降至$16。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发